{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:43:45Z","timestamp":1792197825346,"version":"4.4.0"},"reference-count":44,"publisher":"IMR Press","issue":"3","license":[{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Integr. Neurosci."],"abstract":"<jats:p>Recently, novel non-pharmacological interventions, such as photobiomodulation (PBM) therapy, have shown promise for the treatment of Alzheimer\u2019s disease (AD). This article outlines the translation from the preclinical to clinical stages of an innovative brain\u2013gut PBM therapy in a mouse model of AD, a pilot clinical trial involving mild-to-moderate AD patients, and a continuing pivotal clinical trial with a similar patient population. In a mouse model of AD (A\u03b225-35), daily application of brain\u2013gut PBM therapy to both the head and the abdomen produced a neuroprotective effect against the neurotoxic effects of an A\u03b225-35 peptide injection by normalizing all the modified behavioral and biochemical parameters. The pilot clinical trial to evaluate brain\u2013gut PBM therapy demonstrated the tolerability and feasibility of the novel PBM-based treatment for mild-to-moderate AD patients. Compared to the sham patients, the PBM-treated patients had lower Alzheimer\u2019s Disease Assessment Scale\u2013Cognitive Subscale (ADAS-Cog) comprehension sub-scores, higher forward verbal spans, and lower Trail Making Test (TMT) Part B (TMT-B) execution times, which suggest an improvement in cognitive functions. This pilot study provided important information for the design of a novel pivotal clinical trial, currently in progress, to assess the efficacy of brain\u2013gut PBM therapy in a larger sample of AD patients. This pivotal clinical trial could demonstrate that brain\u2013gut PBM therapy is a safe, well-tolerated, and efficient disease-modifying treatment for mild-to-moderate AD patients and that it has medical and economic benefits.<\/jats:p>","DOI":"10.31083\/j.jin2303057","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T02:23:10Z","timestamp":1710728590000},"source":"Crossref","is-referenced-by-count":8,"title":["Translation from Preclinical Research to Clinical Trials: Brain\u2013Gut Photobiomodulation Therapy for Alzheimer's Disease"],"prefix":"10.31083","volume":"23","author":[{"given":"Guillaume","family":"Blivet","sequence":"first","affiliation":[{"name":"REGEnLIFE, 75008 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois J.","family":"Roman","sequence":"first","affiliation":[{"name":"FRconsulting, 34800 Clermont l'H\u00e9rault, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Delrieu","sequence":"first","affiliation":[{"name":"Maintain Aging Research Team, CERPOP, Universit\u00e9 de Toulouse, Inserm, Universit\u00e9 Paul Sabatier, 31000, Toulouse, France"},{"name":"G\u00e9rontop\u00f4le, Department of Geriatrics, Toulouse University Hospital, 31000, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Touchon","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Montpellier, 34000 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2021 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s & Dementia. 2021; 17: 327\u2013406.","DOI":"10.1002\/alz.12328"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Aryutova K, Paunova R, Kandilarova S, Todeva-Radneva A, Stoyanov D. Implications from translational cross-validation of clinical assessment tools for diagnosis and treatment in psychiatry. World Journal of Psychiatry. 2021; 11: 169\u2013180.","DOI":"10.5498\/wjp.v11.i5.169"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Gu L, Xu H, Qian F. Effects of Non-Invasive Brain Stimulation on Alzheimer\u2019s Disease. The Journal of Prevention of Alzheimer\u2019s Disease. 2022; 9: 410\u2013424.","DOI":"10.14283\/jpad.2022.40"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Ning S, Jorfi M, Patel SR, Kim DY, Tanzi RE. Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer\u2019s Disease. Frontiers in Neuroscience. 2022; 16: 854992.","DOI":"10.3389\/fnins.2022.854992"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Rojas JC, Gonzalez-Lima F. Neurological and psychological applications of transcranial lasers and LEDs. Biochemical Pharmacology. 2013; 86: 447\u2013457.","DOI":"10.1016\/j.bcp.2013.06.012"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Benussi A, Cantoni V, Cotelli MS, Cotelli M, Brattini C, Datta A, et al. Exposure to gamma tACS in Alzheimer\u2019s disease: A randomized, double-blind, sham-controlled, crossover, pilot study. Brain Stimulation. 2021; 14: 531\u2013540.","DOI":"10.1016\/j.brs.2021.03.007"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Khedr EM, Salama RH, Abdel Hameed M, Abo Elfetoh N, Seif P. Therapeutic Role of Transcranial Direct Current Stimulation in Alzheimer Disease Patients: Double-Blind, Placebo-Controlled Clinical Trial. Neurorehabilitation and Neural Repair. 2019; 33: 384\u2013394.","DOI":"10.1177\/1545968319840285"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Gauthier S, Aisen PS, Cummings J, Detke MJ, Longo FM, Raman R, et al. Non-Amyloid Approaches to Disease Modification for Alzheimer\u2019s Disease: An EU\/US CTAD Task Force Report. The Journal of Prevention of Alzheimer\u2019s Disease. 2020; 7: 152\u2013157.","DOI":"10.14283\/jpad.2020.18"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Ziemann U. Thirty years of transcranial magnetic stimulation: where do we stand? Experimental Brain Research. 2017; 235: 973\u2013984.","DOI":"10.1007\/s00221-016-4865-4"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics. 2017; 4: 337\u2013361.","DOI":"10.3934\/biophy.2017.3.337"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochemistry and Photobiology. 2018; 94: 199\u2013212.","DOI":"10.1111\/php.12864"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Hashmi JT, Huang YY, Sharma SK, Kurup DB, De Taboada L, Carroll JD, et al. Effect of pulsing in low-level light therapy. Lasers in Surgery and Medicine. 2010; 42: 450\u2013466.","DOI":"10.1002\/lsm.20950"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Swerdlow RH, Burns JM, Khan SM. The Alzheimer\u2019s disease mitochondrial cascade hypothesis. Journal of Alzheimer\u2019s Disease. 2010; 20: S265\u2013S279.","DOI":"10.3233\/JAD-2010-100339"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Guerriero F, Sgarlata C, Francis M, Maurizi N, Faragli A, Perna S, et al. Neuroinflammation, immune system and Alzheimer disease: searching for the missing link. Aging Clinical and Experimental Research. 2017; 29: 821\u2013831.","DOI":"10.1007\/s40520-016-0637-z"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Chan AS, Lee TL, Hamblin MR, Cheung MC. Photobiomodulation Enhances Memory Processing in Older Adults with Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy Study. Journal of Alzheimer\u2019s Disease. 2021; 83: 1471\u20131480.","DOI":"10.3233\/JAD-201600"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Nizamutdinov D, Qi X, Berman MH, Dougal G, Dayawansa S, Wu E, et al. Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia. Aging and Disease. 2021; 12: 954\u2013963.","DOI":"10.14336\/AD.2021.0229"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Qi X, Nizamutdinov D, Berman MH, Dougal G, Chazot PL, Wu E, et al. Gender Differences of Dementia in Response to Intensive Self-Administered Transcranial and Intraocular Near-Infrared Stimulation. Cureus. 2021; 13: e16188.","DOI":"10.7759\/cureus.16188"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Forsythe P, Bienenstock J, Kunze WA. Vagal Pathways for Microbiome-Brain-Gut Axis Communication. In Lyte M, Cryan JF (eds) Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease (pp.115\u2013133). Springer New York: New York, NY. 2014.","DOI":"10.1007\/978-1-4939-0897-4_5"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Dileone M, Mordillo-Mateos L, Oliviero A, Foffani G. Long-lasting effects of transcranial static magnetic field stimulation on motor cortex excitability. Brain Stimulation. 2018; 11: 676\u2013688.","DOI":"10.1016\/j.brs.2018.02.005"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Kirimoto H, Tamaki H, Otsuru N, Yamashiro K, Onishi H, Nojima I, et al. Transcranial Static Magnetic Field Stimulation over the Primary Motor Cortex Induces Plastic Changes in Cortical Nociceptive Processing. Frontiers in Human Neuroscience. 2018; 12: 63.","DOI":"10.3389\/fnhum.2018.00063"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Oliviero A, Mordillo-Mateos L, Arias P, Panyavin I, Foffani G, Aguilar J. Transcranial static magnetic field stimulation of the human motor cortex. The Journal of Physiology. 2011; 589: 4949\u20134958.","DOI":"10.1113\/jphysiol.2011.211953"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Oliviero A, Carrasco-L\u00f3pez MC, Campolo M, Perez-Borrego YA, Soto-Le\u00f3n V, Gonzalez-Rosa JJ, et al. Safety Study of Transcranial Static Magnetic Field Stimulation (tSMS) of the Human Cortex. Brain Stimulation. 2015; 8: 481\u2013485.","DOI":"10.1016\/j.brs.2014.12.002"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"HALEY TJ, MCCORMICK WG. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. British Journal of Pharmacology and Chemotherapy. 1957; 12: 12\u201315.","DOI":"10.1111\/j.1476-5381.1957.tb01354.x"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Blivet G, Meunier J, Roman FJ, Touchon J. Neuroprotective effect of a new photobiomodulation technique against A\u03b225-35 peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer\u2019s disease suggested. Alzheimer\u2019s & Dementia. 2018; 4: 54\u201363.","DOI":"10.1016\/j.trci.2017.12.003"},{"key":"ref25","unstructured":"Touchon J AL, Meunier J, Ceolin L, Roman FJ, Burcelin R, Blivet GJ. The neuroprotective effect of a new photobiomodulation technique on A\u03b225-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis. The Journal of Prevention of Alzheimer\u2019s Disease. 2018; 5: S29\u2013S30."},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Blivet G, Relano-Gines A, Wachtel M, Touchon J. A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance. Journal of Alzheimer\u2019s Disease. 2022; 90: 811\u2013822.","DOI":"10.3233\/JAD-220467"},{"key":"ref27","unstructured":"Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer\u2019s Disease (LIGHT4LIFE). 2023. Available at: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05926011 (Accessed: 30 July 2023)."},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Wang M, Cao J, Amakye WK, Gong C, Li Q, Ren J. Mid infrared light treatment attenuates cognitive decline and alters the gut microbiota community in APP\/PS1 mouse model. Biochemical and Biophysical Research Communications. 2020; 523: 60\u201365.","DOI":"10.1016\/j.bbrc.2019.12.015"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Grillo SL, Duggett NA, Ennaceur A, Chazot PL. Non-invasive infra-red therapy (1072 nm) reduces \u03b2-amyloid protein levels in the brain of an Alzheimer\u2019s disease mouse model, TASTPM. Journal of Photochemistry and Photobiology. B, Biology. 2013; 123: 13\u201322.","DOI":"10.1016\/j.jphotobiol.2013.02.015"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Chen Q, Wu J, Dong X, Yin H, Shi X, Su S, et al. Gut flora-targeted photobiomodulation therapy improves senile dementia in an A\u00df-induced Alzheimer\u2019s disease animal model. Journal of Photochemistry and Photobiology. B, Biology. 2021; 216: 112152.","DOI":"10.1016\/j.jphotobiol.2021.112152"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Rojas JC, Bruchey AK, Gonzalez-Lima F. Low-level light therapy improves cortical metabolic capacity and memory retention. Journal of Alzheimer\u2019s Disease. 2012; 32: 741\u2013752.","DOI":"10.3233\/JAD-2012-120817"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"De Taboada L, Yu J, El-Amouri S, Gattoni-Celli S, Richieri S, McCarthy T, et al. Transcranial laser therapy attenuates amyloid-\u03b2 peptide neuropathology in amyloid-\u03b2 protein precursor transgenic mice. Journal of Alzheimer\u2019s Disease. 2011; 23: 521\u2013535.","DOI":"10.3233\/JAD-2010-100894"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Lu Y, Wang R, Dong Y, Tucker D, Zhao N, Ahmed ME, et al. Low-level laser therapy for beta amyloid toxicity in rat hippocampus. Neurobiology of Aging. 2017; 49: 165\u2013182.","DOI":"10.1016\/j.neurobiolaging.2016.10.003"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Purushothuman S, Johnstone DM, Nandasena C, van Eersel J, Ittner LM, Mitrofanis J, et al. Near infrared light mitigates cerebellar pathology in transgenic mouse models of dementia. Neuroscience Letters. 2015; 591: 155\u2013159.","DOI":"10.1016\/j.neulet.2015.02.037"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"da Luz Eltchechem C, Salgado ASI, Z\u00e2ngaro RA, da Silva Pereira MC, Kerppers II, da Silva LA, et al. Transcranial LED therapy on amyloid-\u03b2 toxin 25-35 in the hippocampal region of rats. Lasers in Medical Science. 2017; 32: 749\u2013756.","DOI":"10.1007\/s10103-017-2156-3"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Meunier J, Ieni J, Maurice T. The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. British Journal of Pharmacology. 2006; 149: 998\u20131012.","DOI":"10.1038\/sj.bjp.0706927"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Monteiro F, Carvalho \u00d3, Sousa N, Silva FS, Sotiropoulos I. Photobiomodulation and visual stimulation against cognitive decline and Alzheimer\u2019s disease pathology: A systematic review. Alzheimer\u2019s & Dementia. 2022; 8: e12249.","DOI":"10.1002\/trc2.12249"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Ailioaie LM, Ailioaie C, Litscher G. Photobiomodulation in Alzheimer\u2019s Disease-A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine? Pharmaceutics. 2023; 15: 916.","DOI":"10.3390\/pharmaceutics15030916"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Chandra S, Sisodia SS, Vassar RJ. The gut microbiome in Alzheimer\u2019s disease: what we know and what remains to be explored. Molecular Neurodegeneration. 2023; 18: 9.","DOI":"10.1186\/s13024-023-00595-7"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, et al. Gut microbiome alterations in Alzheimer\u2019s disease. Scientific Reports. 2017; 7: 13537.","DOI":"10.1038\/s41598-017-13601-y"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Bonfili L, Cecarini V, Berardi S, Scarpona S, Suchodolski JS, Nasuti C, et al. Microbiota modulation counteracts Alzheimer\u2019s disease progression influencing neuronal proteolysis and gut hormones plasma levels. Scientific Reports. 2017; 7: 2426.","DOI":"10.1038\/s41598-017-02587-2"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Bicknell B, Laakso EL, Liebert A, Kiat H. Modifying the Microbiome as a Potential Mechanism of Photobiomodulation: A Case Report. Photobiomodulation, Photomedicine, and Laser Surgery. 2022; 40: 88\u201397.","DOI":"10.1089\/photob.2021.0057"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Liebert A, Bicknell B, Johnstone DM, Gordon LC, Kiat H, Hamblin MR. \u201cPhotobiomics\u201d: Can Light, Including Photobiomodulation, Alter the Microbiome? Photobiomodulation, Photomedicine, and Laser Surgery. 2019; 37: 681\u2013693.","DOI":"10.1089\/photob.2019.4628"},{"key":"ref44","unstructured":"Delrieu J R-GA, Cristofini P, Bisiaux J, Guillemin S, Blivet G, Touchon J. Does brain-gut photobiomodulation have therapeutic potential in Alzheimer\u2019s disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation. The Journal of Prevention of Alzheimer\u2019s Disease 2022; 9: S82."}],"container-title":["Journal of Integrative Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/JIN\/23\/3\/10.31083\/j.jin2303057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T16:27:21Z","timestamp":1732724841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/JIN\/23\/3\/10.31083\/j.jin2303057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"alternative-id":["S0219-6352(23)00680-0"],"URL":"https:\/\/doi.org\/10.31083\/j.jin2303057","relation":{},"ISSN":["0219-6352","1757-448X"],"issn-type":[{"value":"0219-6352","type":"print"},{"value":"1757-448X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]},"article-number":"57"}}